Zhiyi Pharmaceutics specializes in the research and development of second-generation probiotics and Live Biotherapeutics to enhance gut health and restore microbial balance. Their products aim to address gastrointestinal disorders and improve overall health outcomes through targeted microbiome modulation.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals suffer from gastrointestinal disorders and microbial imbalances that negatively impact their overall health. Current probiotic solutions may lack the specificity and efficacy needed to effectively restore a healthy gut microbiome.
Solution
Zhiyi Pharmaceutics focuses on the research, development, and commercialization of second-generation probiotics and Live Biotherapeutic Products (LBPs) designed to enhance gut health and restore microbial balance. Their products leverage targeted microbiome modulation to address the root causes of gastrointestinal disorders and improve overall health outcomes. Zhiyi's approach involves identifying and developing specific microbial strains with enhanced efficacy and targeted mechanisms of action. These LBPs aim to provide a more precise and effective approach to microbiome restoration compared to traditional probiotic supplements.
Target Audience
Zhiyi Pharmaceutics targets individuals suffering from gastrointestinal disorders, healthcare professionals seeking advanced probiotic solutions, and researchers in the field of microbiome science.
Features
- Development of second-generation probiotics with enhanced specificity and efficacy.
- Focus on Live Biotherapeutic Products (LBPs) for targeted microbiome modulation.
- Research and development efforts aimed at addressing gastrointestinal disorders.
- Products designed to restore microbial balance and improve overall health outcomes.
- SK08活菌散 I期 clinical trials completed.